Adenylate Kinase 4 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an m6A-Based Epitranscriptomic Mechanism-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adenylate Kinase 4 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an m6A-Based Epitranscriptomic Mechanism

Published:2020-12 Issue:12 Volume:28 Page:2593-2604
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Liu Xiaochuan,Gonzalez Gwendolyn,Dai Xiaoxia,Miao Weili,Yuan Jun,Huang Ming,Bade David,Li Lin,Sun Yuxiang,Wang Yinsheng

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference47 articles.

1. Molecular mechanisms and mode of tamoxifen resistance in breast cancer;Ali;Bioinformation,2016

2. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

3. 17α-estradiol-induced VEGF-A expression in rat pituitary tumor cells is mediated through ER independent but PI3K-Akt dependent signaling pathway;Banerjee;Biochem. Biophys. Res. Commun.,2003

4. Tamoxifen resistance in breast cancer;Chang;Biomol. Ther. (Seoul),2012

5. Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer;Duncan;Cell,2012

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crosstalk of methylation and tamoxifen in breast cancer (Review);Molecular Medicine Reports;2024-08-09

2. Functions and mechanisms of RNA m6A regulators in breast cancer (Review);International Journal of Oncology;2024-07-26

3. Progression of m6A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming;Cell Death Discovery;2024-07-20

4. Targeting ROS in cancer: rationale and strategies;Nature Reviews Drug Discovery;2024-07-09

5. Functions of methyltransferase-like 3 in breast cancer: pathogenesis, drug resistance, and therapeutic target;Breast Cancer Research;2024-07-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3